X
API Suppliers
US DMFs Filed
CEP/COS Certifications
0
JDMFs Filed
Other Certificates
Other Suppliers
USA (Orange Book)
Europe
Canada
0
Australia
South Africa
0
Uploaded Dossiers
0
U.S. Medicaid
Annual Reports
0
https://www.pharmaceutical-technology.com/uncategorized/safinamide-mesylate-zambon-co-multiple-system-atrophy-msa-or-shy-drager-syndrome-or-multi-system-degeneration-likelihood-of-approval/#:~:text=Safinamide%20mesylate%20overview&text=It%20is%20under%20development%20for,syndrome%20and%20amyotrophic%20lateral%20sclerosis.
https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=215902
https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=215945
https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=216020
https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=216020
https://www.zambon.com/en/media/press/2021-05-12-newron-and-zambon-sign-agreement-potentially-pivotal-study-safinamide
https://www.businesswire.com/news/home/20210315005352/en/Newron-Signs-Agreement-for-Starting-a-Potentially-Pivotal-Study-With-Safinamide-in-Parkinson%E2%80%99s-Disease-Patients
https://www.biospectrumasia.com/news/25/17521/eisai-launches-parkinsons-disease-treatment-equfina-in-south-korea.html
https://www.biospectrumasia.com/news/25/17521/eisai-launches-parkinsons-disease-treatment-equfina-in-south-korea.html
https://www.biospectrumasia.com/news/25/16206/korea-approves-equfina-for-parkinsons-treatment.html
https://www.biospectrumasia.com/news/51/16206/korea-approves-equfina-for-parkinsons-treatment.html
https://www.globenewswire.com/news-release/2020/04/28/2023750/0/en/Supernus-to-Acquire-CNS-Portfolio-from-US-WorldMeds.html
https://www.newswire.ca/news-releases/valeo-pharma-s-onstryv-r-receives-positive-recommendation-for-public-reimbursement-in-quebec-853697471.html
https://seekingalpha.com/news/3500881-newrons-safinamide-okd-japan-parkinsons
https://www.thepharmaletter.com/article/zambon-and-valeo-pharma-launch-pd-drug-onstryv-in-canada
https://www.zambon.com/en/media/press/2019-07-11-valeo-pharma-announces-canadian-launch-onstryvr-safinamide-tablets-treatment
https://www.biospace.com/article/releases/newron-receives-first-tranche-from-financing-agreement-with-european-investment-bank-eib-/?s=75
https://www.zambon.com/en/media/press/2019-01-15-valeo-pharma-and-zambon-announce-approval-onstryvr-safinamide-canada
https://www.businesswire.com/news/home/20180208006174/en/Newron-Pharmaceuticals-S.p.A.-Announces-Change-Board-Directors
https://au.finance.yahoo.com/news/eisai-primary-endpoint-met-phase-092000398.html
https://www.fiercebiotech.com/biotech/after-disappointing-2016-new-drug-approvals-roared-back-to-life-2017
https://www.thepharmaletter.com/article/zambon-and-seqirus-will-collaborate-to-sell-new-parkinson-s-treatment
https://www.zambon.com/en/media/press/2017-07-11-xadagor-safinamide-now-available-us-parkinsons-disease-patients
http://www.businesswire.com/news/home/20170410005098/en/Valeo-Pharma-Zambon-Form-Partnership-Parkinson%E2%80%99s-Disease/?feedref=JjAwJuNHiystnCoBq_hl-WFAllVCLJFCqzlmaJ8DKHU4plfPZtlGYRDUHCSmgbii6XkLWuQZD-HgGRnjQvCyg3iCfEFIaJW7-otp9V1XQiK2eHTJy3ZqOEt7kKgLu20J
http://www.fiercebiotech.com/biotech/newron-hopes-to-partner-would-be-schizophrenia-blockbuster-year
http://www.pmlive.com/pharma_news/newron_back_on_track_for_xadago_approval_in_us_1126516
http://www.fiercebiotech.com/story/newron-faces-further-fda-delay-parkinsons-drug-regulator-demands-addiction/2016-03-30
https://www.pharmacompass.com/pdf/news/newron-pharmaceuticals-xadago-approved-in-eu-to-treat-parkinsons-disease-1446892265.pdf
http://www.fiercebiotech.com/story/fda-puts-its-decision-newrons-parkinsons-drug/2015-09-30
http://www.ema.europa.eu/docs/en_GB/document_library/EPAR_-_Summary_for_the_public/human/002396/WC500184968.pdf
Market Place
Share 
